Cite
HARVARD Citation
Jantarabenjakul, W. et al. (2018). Pharmacokinetics of Rilpivirine and 24-Week Outcomes after Switching from Efavirenz in Virologically Suppressed HIV-1-Infected Adolescents. Antiviral therapy. 23 (3), pp. 259-265. [Online].